Real-world Prevalence of Adverse Events after Initiating Sacubitril/Valsartan Compared to ACE Inhibitors or ARBs in Heart Failure

Sarah Adie; Abbas Bitar; Kristen Pogue; Sarah Hanigan; Mike Dorsch

首页> 外文期刊>Journal of cardiac failure >Real-world Prevalence of Adverse Events after Initiating Sacubitril/Valsartan Compared to ACE Inhibitors or ARBs in Heart Failure

【24h】

Real-world Prevalence of Adverse Events after Initiating Sacubitril/Valsartan Compared to ACE Inhibitors or ARBs in Heart Failure

机译：与心力衰竭的ACE抑制剂或ARBS相比，启动Sacubitril / Valsartan后的不良事件的现实世界患病率

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of cardiac failure 》 |2018年第8期| 共1页
作者
Sarah Adie; Abbas Bitar; Kristen Pogue; Sarah Hanigan; Mike Dorsch;
展开▼
作者单位

University of Michigan;

University of Michigan;

University of Michigan;

University of Michigan;

University of Michigan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病 ;
关键词

相似文献

外文文献
中文文献
专利

1. Real-world Prevalence of Adverse Events after Initiating Sacubitril/Valsartan Compared to ACE Inhibitors or ARBs in Heart Failure [J] . Sarah Adie, Abbas Bitar, Kristen Pogue, Journal of cardiac failure . 2018 ,第8期

机译：与心力衰竭的ACE抑制剂或ARBS相比，启动Sacubitril / Valsartan后的不良事件的现实世界患病率
2. Real-world Prevalence of Adverse Events after Initiating Sacubitril/Valsartan Compared to ACE Inhibitors or ARBs in Heart Failure [J] . Sarah Adie, Abbas Bitar, Kristen Pogue, Journal of cardiac failure . 2018 ,第8期

机译：与心力衰竭的ACE抑制剂或ARBS相比，启动Sacubitril / Valsartan后的不良事件的现实世界患病率
3. Real-World Prevalence of Adverse Events After Initiating Sacubitril/Valsartan Compared With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Systolic Heart Failure [J] . Adie Sarah, Bitar Abbas, Hanigan Sarah, Journal of cardiac failure . 2019 ,第5期

机译：与血管紧张素转化酶抑制剂或血管紧张素受体阻滞剂在收缩性心力衰竭中相比，在发起Sacubitril / Valsartan后的现实世界患病率
4. MODELING AND ESTIMATION OF COMMON CAUSE FAILURE LIKE PRE-INITIATOR HUMAN FAILURE EVENTS USING EXPERIENCE DATA [C] . Young G. Jo International topical meeting on probabilistic safety assessment and analysis(PSA 2008) . 2008

机译：使用经验数据模拟和估算类似于预启动器的人为故障事件的常见原因
5. Efficacy of Sacubitril/Valsartan in the Treatment of Women with Heart Failure with Preserved Ejection Fraction [D] . Lee, Rita Joyce. 2020

机译：Sacubitril / Valsartan在患有射血分数的心力衰竭治疗妇女的疗效
6. Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM‐HF) [O] . Ulrik M. Mogensen, Jianjian Gong, Pardeep S. Jhund, -1

机译：在心力衰竭试验（PARADIGM-HF）中将ARCI与ACEI进行前瞻性比较确定沙威比曲/缬沙坦对复发事件的影响以确定对全球死亡率和发病率的影响
7. 130 Effects of Sacubitril-Valsartan compared to ACE Inhibitors/Angiotensin Receptor Blockers on Renal Outcomes in Patients with Heart Failure: A Systematic Review and Meta-Analysis [O] . 2020

机译：与ACE抑制剂/血管紧张素受体阻滞剂对心力衰竭患者肾果菌的肾脏结果相比，SACUBITRIL-VALSARTAN的影响：系统审查和荟萃分析

Real-world Prevalence of Adverse Events after Initiating Sacubitril/Valsartan Compared to ACE Inhibitors or ARBs in Heart Failure

著录项

相似文献

相关主题

期刊订阅